US FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
The US Food and Drug Administration (FDA) has approved the first targeted therapy for metastatic pancreatic cancer, advancing an innovative treatment option for patients with limited choices.
Pancreatic Cancer Therapy | 27/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy